Literature DB >> 19692564

Differentiating culture samples representing coagulase-negative staphylococcal bacteremia from those representing contamination by use of time-to-positivity and quantitative blood culture methods.

Christelle Kassis1, Gopi Rangaraj, Ying Jiang, Ray Y Hachem, Issam Raad.   

Abstract

Differentiating true coagulase-negative staphylococcal infection from contamination has an important impact on therapeutic implications. Time to positivity reflects bacterial density and may help in the interpretation of blood cultures. We retrospectively reviewed the records of 272 patients from June 2005 to January 2008 for clinical characteristics, microbiological data, and therapeutic outcome. Four groups were identified. The first three groups, as follows, included patients with one positive quantitative blood culture: the low-colony-count group (<10 CFU/ml), the moderate-colony-count group (30 to 100 CFU/ml), and the high-colony-count group (>100 CFU/ml). The control group included patients with two positive quantitative blood cultures and definite coagulase-negative staphylococcal bloodstream infection. The high-colony-count group had shorter time to positivity (< or = 16 h) than did the low-colony-count group (P < 0.0001). The low-colony-count group had a significantly longer time to positivity, >20 h (P = 0.001), than did the moderate-colony-count group. Even though antibiotics were not provided in 71% of cases and central venous catheter was retained in 83%, the low-colony-count group had a favorable outcome, suggesting that <10 CFU/ml represents contamination. The high-colony-count group, similar to the positive control group, required antibiotics in 81% of cases and central venous catheter removal in 51% (P = 0.001). A time to positivity of < or = 16 h reflects high-grade bacteremia with CFU of >100. Similar to the positive control group, these patients required an active therapeutic approach. A time to positivity of >20 h indicates possible contamination with a CFU of <10, and active therapy may not be required.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19692564      PMCID: PMC2756952          DOI: 10.1128/JCM.01045-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

Review 1.  Guidelines for the management of intravascular catheter-related infections.

Authors:  L A Mermel; B M Farr; R J Sherertz; I I Raad; N O'Grady; J S Harris; D E Craven
Journal:  Clin Infect Dis       Date:  2001-04-03       Impact factor: 9.079

2.  Relevance of the number of positive bottles in determining clinical significance of coagulase-negative staphylococci in blood cultures.

Authors:  S Mirrett; M P Weinstein; L G Reimer; M L Wilson; L B Reller
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

3.  Prospective study of the value of quantitative culture of organisms from blood collected through central venous catheters in differentiating between contamination and bloodstream infection.

Authors:  Ioannis Chatzinikolaou; Hend Hanna; Rabih Darouiche; George Samonis; Jeffrey Tarrand; Issam Raad
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

4.  The use of continuous monitoring blood culture systems in the diagnosis of catheter related sepsis.

Authors:  M S Rogers; B A Oppenheim
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

5.  Earlier positivity of central-venous- versus peripheral-blood cultures is highly predictive of catheter-related sepsis.

Authors:  F Blot; E Schmidt; G Nitenberg; C Tancrède; B Leclercq; A Laplanche; A Andremont
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

6.  Initial concentration of Staphylococcus epidermidis in simulated pediatric blood cultures correlates with time to positive results with the automated, continuously monitored BACTEC blood culture system.

Authors:  Yishai Haimi-Cohen; Ernestine M Vellozzi; Lorry G Rubin
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

7.  Specimen volume versus yield in the BACTEC blood culture system.

Authors:  J J Plorde; F C Tenover; L G Carlson
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

8.  Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States.

Authors:  Hilmar Wisplinghoff; Harald Seifert; Richard P Wenzel; Michael B Edmond
Journal:  Clin Infect Dis       Date:  2003-04-14       Impact factor: 9.079

9.  Clinical comparison of the resin-containing BACTEC 26 Plus and the Isolator 10 blood culturing systems.

Authors:  J J Tarrand; C Guillot; M Wenglar; J Jackson; J D Lajeunesse; K V Rolston
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

10.  Use of incubation time to detection in BACTEC 9240 to distinguish coagulase-negative staphylococcal contamination from infection in pediatric blood cultures.

Authors:  Yishai Haimi-Cohen; Shideh Shafinoori; Victor Tucci; Lorry G Rubin
Journal:  Pediatr Infect Dis J       Date:  2003-11       Impact factor: 2.129

View more
  16 in total

1.  Evaluation of quantitative antibiotic susceptibility testing by Vitek 2 as a routine method to predict strain relatedness of coagulase-negative staphylococci isolated from blood cultures.

Authors:  Antonia Camerer; Anke Kohlenberg; Danuta Stefanik; Harald Seifert
Journal:  J Clin Microbiol       Date:  2011-07-27       Impact factor: 5.948

2.  Neutralization of antimicrobial substances in new BacT/Alert FA and FN Plus blood culture bottles.

Authors:  Dieter Mitteregger; Wolfgang Barousch; Marion Nehr; Michael Kundi; Markus Zeitlinger; Athanasios Makristathis; Alexander M Hirschl
Journal:  J Clin Microbiol       Date:  2013-03-13       Impact factor: 5.948

3.  Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer.

Authors:  Anne-Marie Chaftari; Ray Hachem; Mary Jordan; Kumait Garoge; Zainab Al Hamal; Aline El Zakhem; George M Viola; Bruno Granwehr; Victor Mulanovich; Andrew Gagel; Ruth Reitzel; Ammar Yousif; Ying Jiang; Issam Raad
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

Review 4.  Population-based epidemiology and microbiology of community-onset bloodstream infections.

Authors:  Kevin B Laupland; Deirdre L Church
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

5.  Evaluation of a commercial multiplex PCR test (SeptiFast) in the etiological diagnosis of community-onset bloodstream infections.

Authors:  P Josefson; K Strålin; A Ohlin; T Ennefors; B Dragsten; L Andersson; H Fredlund; P Mölling; P Olcén
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-03-04       Impact factor: 3.267

6.  True bacteremias caused by coagulase negative Staphylococcus are difficult to distinguish from blood culture contaminants.

Authors:  M Rahkonen; S Luttinen; M Koskela; T Hautala
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-31       Impact factor: 3.267

Review 7.  Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus.

Authors:  M Widerström; J Wiström; A Sjöstedt; T Monsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

8.  Blood drawn through valved catheter hub connectors carries a significant risk of contamination.

Authors:  R J Sherertz; T B Karchmer; E Palavecino; W Bischoff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

9.  Time to positivity of blood culture and its prognostic value in bloodstream infection.

Authors:  Y Ning; R Hu; G Yao; S Bo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-29       Impact factor: 3.267

10.  Duplex DNA-Invading γ-Modified Peptide Nucleic Acids Enable Rapid Identification of Bloodstream Infections in Whole Blood.

Authors:  Jörk Nölling; Srinivas Rapireddy; Joel I Amburg; Elizabeth M Crawford; Ranjit A Prakash; Arthur R Rabson; Yi-Wei Tang; Alon Singer
Journal:  mBio       Date:  2016-04-19       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.